Alphatec Spine Adds New Vice President and General Manager, Latin America

Share this story with your network

CARLSBAD, Calif., May 5, 2010 (GlobeNewswire via COMTEX) — Alphatec Holdings, Inc.(ATEC 6.21, -0.20, -3.12%), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that Armin Weichert, who has over 25 years of sales and management experience in the medical device and life sciences industries, has been named the Company’s new Vice President and General Manager, Latin America.

Mr. Weichert, who will be based in Brazil, fills this newly created position to oversee all of Alphatec Spine’s Latin American operations. He will be responsible for directing and overseeing Alphatec Spine’s marketing and sales expansion in Latin America, including efforts to secure experienced spine product distributors that will exclusively sell the Company’s products, as well as building relationships with key medical opinion leaders.

Most recently, Mr. Weichert served as the Division Director in Brazil for Aesculap, AG, a position he held for over 10 years, in which he was responsible for managing all of Aesculap’s operations in Brazil. Mr. Weichert has worked at Aesculap for over 20 years, and has had increasing roles of business development and sales responsibility.

“We are pleased that we were able to successfully attract someone with a background as strong as Armin’s to lead our Latin American operations,” said Dirk Kuyper, the Company’s President and Chief Executive Officer. “Given his wealth of experience in medical device sales and marketing in that region of the world, we believe he will provide a significant boost to our Latin American business.”

About Alphatec Spine

Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc.(ATEC 6.21, -0.20, -3.12%). Alphatec Spine is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company’s mission is to combine world-class customer service with innovative, surgeon-driven design that will help improve the aging patient’s quality of life. The Company is poised to achieve its goal through new solutions for patients with osteoporosis, stenosis and other aging spine deformities, improved minimally invasive products and techniques and integrated biologics solutions. In addition to its U.S. operations, the Company also markets its products in over 50 international markets through its subsidiary, Scient’x S.A., via a direct salesforce in France, Italy and the United Kingdom and via independent distributors in the rest of Europe, the Middle East and Africa, South America and Latin America. In Asia and Australia, the Company markets its products through its subsidiary, Alphatec Pacific, Inc, and through Scient’x’s distributors in China, Korea and Australia.

The Alphatec Holdings, Inc. logo is available athttp://www.globenewswire.com/newsroom/prs/?pkgid=3520

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: Alphatec Holdings, Inc.

Leave a Comment

Your email address will not be published. Required fields are marked *

*